Prescription Drug Search Results: Losartan-Hctz

Combined treatment with a dipeptidyl peptidase‐IV inhibitor (sitagliptin) and an angiotensin II type 1 receptor blocker (losartan) promotes islet regeneration via enhanced differentiation of pancreatic progenitor cells
Conclusions: These data indicate that combined sitagliptin‐losartan treatment can improve islet function by promoting the differentiation of PPCs into ICCs, perhaps via a mechanism involving PPARγ production, and could thereby, contribute to islet regeneration. (Source: Diabetes, Obesity and Metabolism)

Zimbabwe: Binding Research and Development Convention Takes Centre Stage
[The Herald] THE world's health ministers, gathering in Geneva for the World Health Assembly this week, will decide whether or not to start the process for a binding agreement that would jumpstart research and development (RD) for medical needs that are currently unmet. (Source: AllAfrica News: Health and Medicine)